• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜治疗难治性丝虫性乳糜尿:初步报告

Endoscopic treatment of refractory filarial chyluria: a preliminary report.

作者信息

Yagi S, Goto T, Kawamoto K, Miyawaki I, Tanaka I, Mori K, Hayami H, Ohi Y

机构信息

Department of Urology, Kagoshima University Hospital, Japan.

出版信息

J Urol. 1998 May;159(5):1615-8. doi: 10.1097/00005392-199805000-00055.

DOI:10.1097/00005392-199805000-00055
PMID:9554365
Abstract

PURPOSE

We report our experiences treating 5 patients who had filarial chyluria using an endoscopic approach.

MATERIALS AND METHODS

Two men and 3 women 47 to 83 years old with chyluria were treated with endoscopic coagulation using guide tube methods. Intrarenal pelvic instillation of silver nitrate was not effective in 4 patients and catheterization was impossible in 1.

RESULTS

The responsible lesion was successfully coagulated in all 5 patients. Because the lesion was in the ruptured portion of the caliceal fornix, we thought that chyluria had arisen in the fragile portion of the fornix (fistulization). After endoscopic treatment there was no recurrence in any patient.

CONCLUSIONS

Endoscopy is effective and minimally invasive therapy for filarial chyluria.

摘要

目的

我们报告使用内镜方法治疗5例丝虫性乳糜尿患者的经验。

材料与方法

对2名男性和3名女性,年龄在47至83岁的乳糜尿患者采用导管引导下的内镜凝血治疗。4例患者肾内肾盂灌注硝酸银无效,1例无法进行插管。

结果

所有5例患者的责任病灶均成功凝固。由于病灶位于肾盏穹窿破裂处,我们认为乳糜尿起源于穹窿的脆弱部分(形成瘘管)。内镜治疗后,所有患者均未复发。

结论

内镜检查是治疗丝虫性乳糜尿的有效且微创的方法。

相似文献

1
Endoscopic treatment of refractory filarial chyluria: a preliminary report.内镜治疗难治性丝虫性乳糜尿:初步报告
J Urol. 1998 May;159(5):1615-8. doi: 10.1097/00005392-199805000-00055.
2
Retroperitoneoscopic lymphatic management of intractable chyluria.后腹腔镜下难治性乳糜尿的淋巴处理
J Urol. 2002 Jun;167(6):2473-6.
3
Is povidone iodine an alternative to silver nitrate for renal pelvic instillation sclerotherapy in chyluria?聚维酮碘能否替代硝酸银用于乳糜尿肾盂灌注硬化治疗?
BJU Int. 2004 Nov;94(7):1082-5. doi: 10.1111/j.1464-410X.2004.05108.x.
4
Povidone iodine and dextrose solution combination sclerotherapy in chyluria.聚维酮碘与葡萄糖溶液联合硬化疗法治疗乳糜尿
Urology. 2004 Dec;64(6):1107-9; discussion 1110. doi: 10.1016/j.urology.2004.07.035.
5
Filarial chyluria: long-term experience of a university hospital in India.丝虫性乳糜尿:印度一家大学医院的长期经验
Int J Urol. 2004 Apr;11(4):193-8; discussion 199. doi: 10.1111/j.1442-2042.2003.00761.x.
6
Remission of filarial chyluria after treatment of coexistent conditions.合并症治疗后丝虫性乳糜尿的缓解
Lymphology. 1990 Sep;23(3):164-6.
7
Chyluria with proteinuria or filarial nephropathy? An enigma.乳糜尿合并蛋白尿还是丝虫性肾病?一个谜团。
Parasitol Int. 2007 Sep;56(3):251-4. doi: 10.1016/j.parint.2007.03.002. Epub 2007 Mar 30.
8
Retroperitoneoscopic renal pedicle lymphatic disconnection for chyluria.后腹腔镜肾蒂淋巴管离断术治疗乳糜尿
Chin Med J (Engl). 2003 Nov;116(11):1746-8.
9
Unilateral pedal lymphography in patients with filarial chyluria.
BJU Int. 2000 Feb;85(3):222-3. doi: 10.1046/j.1464-410x.2000.00400.x.
10
[Changes in T-lymphocyte subsets of peripheral blood in patients with filarial chyluria].[丝虫性乳糜尿患者外周血T淋巴细胞亚群的变化]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2000;18(2):103-5.

引用本文的文献

1
Preliminary Study of a Single Instillation of Low-Concentration High-Volume Silver Nitrate Solution for Chyluria: Is >10 mL Instillation an Absolute Contraindication in the Real World?低浓度大容量硝酸银溶液单次灌注治疗乳糜尿的初步研究:在现实世界中,灌注量>10 mL是否绝对禁忌?
Trop Med Infect Dis. 2019 Oct 16;4(4):128. doi: 10.3390/tropicalmed4040128.
2
Hematuria without chyluria: It could still be due to filarial etiology.无乳糜尿的血尿:仍可能由丝虫病因引起。
Trop Parasitol. 2016 Jul-Dec;6(2):151-154. doi: 10.4103/2229-5070.190834.
3
Filariasis in Japan some 25 years after its eradication.
日本丝虫病根除约25年后的情况。
Trop Med Health. 2011 Mar;39(1 Suppl 2):57-63. doi: 10.2149/tmh.39-1-suppl_2-57.